1. Home
  2. MRNA vs AYI Comparison

MRNA vs AYI Comparison

Compare MRNA & AYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRNA
  • AYI
  • Stock Information
  • Founded
  • MRNA 2010
  • AYI 2001
  • Country
  • MRNA United States
  • AYI United States
  • Employees
  • MRNA N/A
  • AYI N/A
  • Industry
  • MRNA Biotechnology: Biological Products (No Diagnostic Substances)
  • AYI Building Products
  • Sector
  • MRNA Health Care
  • AYI Consumer Discretionary
  • Exchange
  • MRNA Nasdaq
  • AYI Nasdaq
  • Market Cap
  • MRNA 9.2B
  • AYI 11.2B
  • IPO Year
  • MRNA 2018
  • AYI N/A
  • Fundamental
  • Price
  • MRNA $24.36
  • AYI $359.53
  • Analyst Decision
  • MRNA Hold
  • AYI Buy
  • Analyst Count
  • MRNA 15
  • AYI 6
  • Target Price
  • MRNA $36.69
  • AYI $395.17
  • AVG Volume (30 Days)
  • MRNA 11.7M
  • AYI 223.7K
  • Earning Date
  • MRNA 11-06-2025
  • AYI 10-01-2025
  • Dividend Yield
  • MRNA N/A
  • AYI 0.19%
  • EPS Growth
  • MRNA N/A
  • AYI N/A
  • EPS
  • MRNA N/A
  • AYI 12.53
  • Revenue
  • MRNA $2,232,000,000.00
  • AYI $4,345,600,000.00
  • Revenue This Year
  • MRNA N/A
  • AYI $10.92
  • Revenue Next Year
  • MRNA $10.38
  • AYI $5.15
  • P/E Ratio
  • MRNA N/A
  • AYI $28.72
  • Revenue Growth
  • MRNA N/A
  • AYI 13.14
  • 52 Week Low
  • MRNA $23.04
  • AYI $216.81
  • 52 Week High
  • MRNA $56.70
  • AYI $375.67
  • Technical
  • Relative Strength Index (RSI)
  • MRNA 43.32
  • AYI 51.12
  • Support Level
  • MRNA $23.48
  • AYI $357.35
  • Resistance Level
  • MRNA $25.56
  • AYI $367.81
  • Average True Range (ATR)
  • MRNA 1.46
  • AYI 8.96
  • MACD
  • MRNA -0.32
  • AYI -1.61
  • Stochastic Oscillator
  • MRNA 15.89
  • AYI 38.61

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

About AYI Acuity Brands Inc.

Acuity is a leading industrial technology company that offers lighting, lighting controls, and intelligent building solutions. Acuity, Inc. designs, manufactures, and brings to market products and services relating to these and other offerings. Acuity, Inc. has two reportable segments: Acuity Brands Lighting and Acuity Intelligent Spaces. ABL sells commercial, architectural, and specialty lighting, including components and control systems. AIS offers building management and audio/visual solutions to help make buildings intelligent.

Share on Social Networks: